Publication | Closed Access

Treatment persistence with adalimumab, etanercept, or infliximab in combination with methotrexate and the effects on health care costs in patients with rheumatoid arthritis

Rheumatoid DisorderRheumatologyMedicineRheumatic DiseasesTreatment OptionInflammatory Rheumatic DiseasePharmacotherapyTreatment PersistencePsoriatic ArthritisHealth Care CostsRheumatoid Arthritis